Hepatic Failure
13
0
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
1 terminated out of 13 trials
83.3%
-3.2% vs benchmark
15%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Personalized Two-stage Regional Citrate Anticoagulation for CRRT in Patients With Citrate Metabolism Impairment
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH
Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment
Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
The Role of Skin Microbiota in Hepatic or Renal Pruritus
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
The Plasma Diafiltration Therapy of Hepatic Failure
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
Liver Function Assessment - Feasibility and Dosing Study
Cardiox Liver Function Test Pivotal Trial
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function